Skip to main content
Earnings Labs
4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ·Healthcare·Biotechnology

$10.21

+1.14%

Mkt Cap $532.17M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (16 analysts)

$33.00

Range $33.00$33.00

Implied Upside

+223.2%

Consensus $33.00 vs current $10.21